Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The norepinephrine transporter (NET), encoded by the SLC6A2 gene, is a transmembrane protein responsible for the sodium-dependent reuptake of extracellular norepinephrine into presynaptic nerve terminals (UniProt P23975). This process serves as the primary mechanism for terminating noradrenergic neurotransmission in both the central and peripheral nervous systems, thereby regulating mood, arousal, and autonomic functions such as heart rate and blood pressure (StatPearls, 'Physiology, Noradrenaline'). In the brain, NET is highly expressed in the locus coeruleus and is critical for maintaining cognitive focus and alertness; notably, it also contributes to dopamine clearance in the prefrontal cortex where dopamine transporters are sparse. Dysregulation of NET is implicated in various psychiatric and neurological conditions, including major depressive disorder, ADHD, and postural orthostatic tachycardia syndrome (POTS) (NIH, 'SLC6A2 gene'). Therapeutic agents targeting NET, such as selective norepinephrine reuptake inhibitors (NRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), are widely utilized to enhance noradrenergic signaling for the treatment of depression, ADHD, and chronic pain (PubChem, 'Atomoxetine'). However, pharmacological inhibition of NET can lead to side effects associated with increased sympathetic tone, necessitating careful monitoring of cardiovascular parameters.
Inhibition of the transporter protein to prevent the clearance of norepinephrine from the synaptic cleft, thereby increasing its extracellular concentration and prolonging its action on postsynaptic adrenergic receptors (StatPearls, 'Physiology, Noradrenaline').
10 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine transporter (NET) (NET).